Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates


Epstein-Barr virus-associated post-transplant lymphoproliferative disorder and sensory polyneuropathy: case report

    • 1 Accesses

    This is a preview of subscription content, log in to check access.


    1. 1.

      In R-CHOP regimen, specific corticosteroid component was not mentioned.


    1. Mika T, et al. Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes. Frontiers in Medicine 6: Dec 2019. Available from: URL:

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Immunosuppressants/immunotherapies. Reactions Weekly 1791, 139 (2020).

    Download citation